US pharma giant launches round two of London healthtech startup programme

US pharma giant Pfizer Ltd has opened applications for the second round of its London-based funding and support programme for healthtech startups.

The initiative, which follows an oversubscribed first year for Pfizer Healthcare Hub: London, will look to help a new raft of innovators working at the cross section between health and technology.

Pfizer wants to support startups that have developed products or services that can demonstrate evidence of benefitting either patients or clinicians.

Participants will compete for a share of a £50k grant and a year-long programme of support.

Erik Nordkamp, managing director of Pfizer UK, said: “Following the success of the 2017 UK Hub, I’m delighted to continue the programme again this year.

“We’re seeing remarkable innovation in healthcare here in the UK, with technology rapidly maturing to meet the needs of patients and clinicians.”

He added: “Analytics, telemedicine and consumer facing apps which accommodate multiple conditions are just some of the technological trends impacting health. Pfizer is committed to continuing to support health tech start-ups in the quest to improve health.”

The Pfizer Healthcare Hub: London is a part of a worldwide network of innovation hubs that includes centres in Berlin, Stockholm, Sydney, North America and Tel Aviv.

Dr Hamish Graham, manager of the Pfizer Healthcare Hub: London, commented: “Digital maturity is coming to the NHS and other UK health services in 2018. Technology is being used to explore innovation at every level of the NHS, to help address some of the serious health challenges patient providers face.

“Taking incredible innovations and turning them into practical applications will be vital to help improve the delivery of healthcare for patients while generating efficiencies so health systems can meet the demands for the people they support.”

Looking to promote your product/service to SME businesses in your region? Find out how Bdaily can help →